SynthesisCurrent oncology (Toronto, Ont.)2022

First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review.

Lan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.